IN20019

N/A

Report date: 2023/04/24 14:30:06
NME

Base Information

Drug NameIN20019
Drug Alias NameIN20019IN-20019
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInxMed (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInxMed (Hong Kong) Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A